missing translation for 'onlineSavingsMsg'
Learn More

Binimetinib, MedChemExpress

Product Code. 16472477
Encompass_Preferred
Click to view available options
Quantité:
10 mg
50 mg
100 mg
200 mg
This item is not returnable. View return policy

Product Code. 16472477

Brand: Medchem Express HY15202

Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!

This item is not returnable. View return policy

MedChemExpress Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor. Binimetinib (MEK162) inhibits MEK with an IC50 of 12 nM.

Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor. Binimetinib (MEK162) inhibits MEK with an IC50 of 12 nM.

Specifications

Nom chimique ou matériau Binimetinib
CAS 606143-89-9
Couleur Off-White
Notes de qualité de la pureté Research
Formule moléculaire C17H15BrF2N4O3
Quantité 50 mg
Synonyme MEK162 ARRY-162 ARRY-438162
Informations sur la solubilité DMSO : 50 mg/mL (113.32 mM; Need ultrasonic)
SMILES BrC1=CC=C(C(F)=C1)NC2=C(C3=C(C=C2C(NOCCO)=O)N(C=N3)C)F
Poids moléculaire (g/mol) 441.23
Poids de la formule 441.23
Pourcentage de pureté 98.05%
Qualité Research
Forme physique Solid
À utiliser avec (application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.